Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: A multicentre retrospective cross-sectional study

Clinical Microbiology and Infection

Volumn 22, Issue 4, 2016, Pages 387.e1-387.e4

  Leblebicioglu, H ^a   Sunbul, M ^a   Guner, R ^b   Bodur, H ^c   Bulut, C ^d   Duygu, F ^e   Elaldi, N ^f   Cicek Senturk, G ^g   Ozkurt, Z ^h   Yilmaz, G ⁱ   Fletcher, T E ^a,j   Beeching, N J ^j,k  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Ankara Research and Training Hospital   (Turkey)

^e GAZIOSMANPASA UNIVERSITY   (Turkey)

^f CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^g DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^h ATATURK UNIVERSITY   (Turkey)

ⁱ KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^j LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^k UNIVERSITY OF LIVERPOOL   (United Kingdom)

more..

Author keywords

Crimean Congo haemorrhagic fever; Healthcare associated; Infection prevention and control; Ribavirin; Viral haemorrhagic fever

Indexed keywords

RIBAVIRIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS RNA;

BLOOD; BLOOD SAMPLING; BODY FLUID; CRIMEAN CONGO HEMORRHAGIC FEVER; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTHCARE ASSOCIATED INFECTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MUCOSA; NEEDLESTICK INJURY; NOTE; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TURKEY (REPUBLIC); VIRUS TRANSMISSION; CLINICAL TRIAL; COMPLICATION; HEMORRHAGIC FEVER, CRIMEAN; HOSPITAL; IMMUNOLOGY; MULTICENTER STUDY; NAIROVIRUS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; SURVIVAL ANALYSIS; TURKEY;

ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEEDLESTICK INJURIES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; SURVIVAL ANALYSIS; TURKEY;

EID: 84959159259     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.11.024     Document Type: Article

References (12)

1. Maltezou H.C., Andonova L., Andraghetti R., Bouloy M., Ergonul O., Jongejan F., et al. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill 2010, 15:19504.
2. Vorou R.M. Crimean-Congo hemorrhagic fever in southeastern Europe. Int J Infect Dis 2009, 13:659-662.
3. Beeching N.J., Fletcher T.E., Hill D.R., Thomson G.L. Travellers and viral haemorrhagic fevers: what are the risks?. Int J Antimicrob Agents 2010, 36(Suppl. 1):S26-S35.
4. Patel A.K., Patel K.K., Mehta M., Parikh T.M., Toshniwal H., Patel K. First Crimean-Congo hemorrhagic fever outbreak in India. J Assoc Physicians India 2011, 59:585-589.
5. Burney M.I., Ghafoor A., Saleen M., Webb P.A., Casals J. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever-Congo virus in Pakistan, January 1976. Am J Trop Med Hyg 1980, 29:941-947.
6. Pshenichnaya N.Y., Nenadskaya S.A. Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. Int J Infect Dis 2015, 33:120-122.
7. Conger N.G., Paolino K.M., Osborn E.C., Rusnak J.M., Günther S., Pool J., et al. Health care response to CCHF in US soldier and nosocomial transmission to health care. Emerg Infect Dis 2015, 21:23-31.
8. Guner R., Hasanoglu I., Tasyaran M.A., Yapar D., Keske S., Guven T., et al. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever?. Vector Borne Zoonotic Dis 2014, 14:601-605.
9. Parlak E., Koşan Z., Ertürk A., Parlak M., Özkut Z. A nosocomial outbreak of Crimean-Congo hemorrhagic fever. J Microbiol Infect Dis 2015, 5:5-9.
10. Leblebicioglu H., Ozaras R., Irmak H., Sencan I. Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges. Antiviral Res 2016 Feb, 126:21-34.
11. Bausch D.G., Hadi C.M., Khan S.H., Lertora J.J.L. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis 2010, 51:1435-1441.
12. Ascioglu S., Leblebicioglu H., Vahaboglu H., Chan K.A. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother 2011, 66:1215-1522.